Pressure BioSciences Inc. PBIO Archives - Page 8 of 22

TuesdayNov 17, 2020 10:12 am

Pressure BioSciences’ (PBIO) First Issued U.S. Patent for Its Novel UST Platform Advances the Company Toward 2021 Product Delivery, Significant Acceleration of Revenue, and Profitability

Life sciences technology innovator Pressure BioSciences (OTCQB: PBIO) has increased its IP stable to 26 patents worldwide with the announcement of its first U.S. patent for its revolutionary Ultra Shear Technology(TM) (“UST”) Platform The patent (US 10,823,159) - entitled “System for High Pressure, High Shear Processing of Fluids” - will be the framework of the company’s new instrument line (the BaroShear K45 Nanoemulsification System) to be commercially released in mid-2021 UST is expected to revolutionize the processing of immiscible liquids into high quality, highly profitable nanoemulsions Nanoemulsions are highly sought after in a variety of industries because of their ability…

WednesdayNov 11, 2020 1:02 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Awarded First US Patent for Revolutionary UST(TM) Platform

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of pressure-based instruments, consumables and platform solutions to the worldwide life sciences and other industries, today announced the award of the first U.S. patent for its revolutionary Ultra Shear Technology(TM) (UST(TM)) platform. The patent, entitled "System for High Pressure, High Shear Processing of Fluids," brings the company's intellectual property ("IP") estate to a total of 26 issued patents. “Nanoemulsions have long been shown to exhibit improved absorption, higher bioavailability and greater stability, while often requiring lower levels of emulsifiers than macro/micro emulsion products,” said Dr. Edmund Y. Ting, Sr.,…

ThursdayOct 15, 2020 2:49 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Path to Commercialization Targets Multibillion Hemp-Derived CBD Market

Pressure BioSciences (OTCQB: PBIO), a developer of innovative solutions for the worldwide life science and other industries, recently achieved another milestone as it nears initial production of commercial systems expected to revolutionize the nanoemulsification process for a wide variety of sectors. The company’s proprietary, next-generation Ultra Shear Technology-based BaroShear K45 System is designed to create unique, high-quality nanoemulsions of otherwise poorly soluble oils in order to render them more easily absorbed and effective in the water-based biology of human bodies. Pressure BioSciences earlier this year announced the launch of its UST Demonstration Laboratory as a place to showcase the technology’s…

MondayOct 12, 2020 11:01 am

Pressure BioSciences (PBIO) Achieves Critical Milestone in Commercial Rollout of Revolutionary Nanoemulsification System

Pressure BioSciences has been making a name for itself as a leader in the development and sale of proprietary intense-pressure delivery systems to the worldwide life sciences field PBIO is developing a novel high pressure platform called Ultra-Shear Technology (“UST”) that processes oil-based solutions into water-soluble nanoemulsions that will allow the molecules inside the oil (e.g., CBD, Vitamins) to be more readily absorbed by human biology Development of th proprietary new instrument - the BaroShear K45-has been proceeding well since the Company received orders for all of its planned initial build of 12 units Pressure BioSciences reported achieving a critical…

TuesdayOct 06, 2020 11:33 am

QualityStocksNewsBreaks – Pressure BioSciences (PBIO) Locks In Final System Design, Begins Production of Alpha Unit

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, and other industries, has reached what it calls as a critical milestone. The company announced the lock-in of final design specifications for the commercial production model of its proprietary, next-generation Ultra Shear Technology(TM)-based nanoemulsification system. In addition, PBIO has begun initial commercial system development of the system. Once the alpha unit has been tested and approved, the company will begin building an additional 15 ready-for-sale systems. This strategy aligns with PBIO’s objective of shipping…

FridayAug 21, 2020 1:10 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Awarded Key Patent for Critical Addition to Instruments, Consumables Product Line

Pressure BioSciences (OTCQB: PBIO) recently announced its receipt of a pivotal U.S. patent for “Sample Preparation Devices and Methods,” which expands its already significant intellectual property (“IP”) portfolio. This award increases Pressure BioSciences’ IP ownership to include 25 issued patents protecting its unique pressure-cycling technology (“PCT”) systems. The newly patented PCT MicroPestle (“MP”) is a critical addition to the company’s instruments and consumables product line. A recent article discussing this reads, “The PCT MP is the company’s most important and popular consumable to date, having a unique construction that seals and protects the sample while flexing to transfer immense pressures…

FridayAug 14, 2020 8:30 am

Pressure BioSciences, Inc. (PBIO) Receives Pivotal U.S. Patent for Novel, High-Pressure Enhanced Consumable Device

Pressure BioSciences develops and sells pressure-based instruments and consumables to the global life sciences, food and beverage, and other large research markets Their products are based on three key technology platforms, led by their proprietary Pressure Cycling Technology (“PCT”) The award of the PCT MicroPestle (“MP”) patent moves Pressure BioSciences even closer to entering the clinical diagnostics market, which is exponentially larger than the research products market where the Company currently transacts business The Company utilizes a “razor: razor blade” business model, and the PCT MP is the Company’s most important and popular consumable to date PBI has seen revenue…

WednesdayAug 12, 2020 12:24 pm

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) Achieves Critical Milestone Through Award of Key Patent

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions to the worldwide life sciences and other industries, today announced the award of a key U.S. patent entitled "Sample Preparation Devices and Methods." According to the update, the new patent (U.S. 10,710,082) brings the company's intellectual property ("IP") estate up to a total of 25 issued patents. "We have many customers worldwide who routinely use our ‘PCT’ Micro-Pestle consumable in their research studies. These include Professor Phil Robinson and his team at the Children's Medical Research Institute in Australia (processing…

WednesdayJul 08, 2020 9:42 am

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) to Host Teleconference to Discuss Q1 2020 Results and Provide Business Update

Pressure BioSciences (OTCQB: PBIO) on Tuesday announced that it will host a teleconference to discuss its first quarter 2020 financial results and to provide a business update, including the Company’s progress made in the development of its Ultra Shear Technology(TM) ("UST(TM)) Platform and in the pending merger of PBI, Cannaworx, and SkinScience Labs. The call is scheduled to take place at 4:30 p.m. Eastern Time on July 8, 2020. Interested parties may join the conference by dialing (844) 602-0380 (North America) or (862) 298-0970 (International) and entering verbal passcode: PBI First Quarter 2020 Financial Call & Business Update. For those…

TuesdayJun 30, 2020 11:23 am

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) and Leica Microsystems Collaborate to Offer Innovative Combined Workflow Expected to Accelerate Cancer R&D

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries, today announced its entry into a worldwide co-marketing agreement with German-based Leica Microsystems CMS GmbH, a Danaher company. Per the update, the historic alliance is expected to offer transformative new empowerment to cancer research worldwide through integrating the latest enabling technologies in capturing, isolating and preparing biopsy samples for superior analysis of relevant biomarkers of disease state and treatment response. "The generation of reliable and reproducible data from biopsy samples is difficult, as it requires…

Site Search

Company Search

Tag: Pressure BioSciences Inc. PBIO